The IL-17 pathway mediated by m6A-modified lncRNA H19: a new mechanism for Jianpi Qingre Tongluo Prescription in repressing inflammation and improving lipid metabolism in gout arthritis

Abstract Background Jianpi Qingre Tongluo Prescription [also named Huangqin Qingrechubi Capsule (HQC)] is an empirical prescription for the treatment of gouty arthritis (GA) with excellent clinical efficacy. Mechanistically, HQC suppresses inflammation and lipid metabolism imbalance in GA by regulat...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Xianheng Zhang, Jian Liu, Xiaolu Chen, Xiang Ding, Shengfeng Liu, Xueni Cheng, Dahai Fang
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2026-03-01
Seri Bilgileri:	Chinese Medicine
Konular:	Gouty arthritis Jianpi Qingre Tongluo Prescription Inflammation Lipid metabolism N6-methyladenosine modification LncRNA H19
Online Erişim:	https://doi.org/10.1186/s13020-026-01379-z
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!